XML 23 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balances (in shares) at Dec. 31, 2015   13,278,824      
Beginning Balance at Dec. 31, 2015 $ 252,348 $ 13,279 $ 110,145 $ 125,112 $ 3,812
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 35,184     35,184  
Other Comprehensive Income (Loss) (10,216)       (10,216)
Cash Dividends ($.60, $.52 and $.48 in 2018, 2017 and 2016, respectively) (10,630)     (10,630)  
Issuance of Common Stock for:          
Exercise of Stock Options (in shares)   4,166      
Exercise of Stock Options 55 $ 4 51    
Acquisitions (in shares)   1,942,429      
Acquisitions 61,919 $ 1,942 59,977    
Restricted Share Grants (in shares)   36,012      
Restricted Share Grants 1,407 $ 36 1,371    
Income Tax Benefit From Restricted Share Vesting 200   200    
Ending Balances (in shares) at Dec. 31, 2016   15,261,431      
Ending Balance at Dec. 31, 2016 330,267 $ 15,261 171,744 149,666 (6,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 40,676     40,676  
Other Comprehensive Income (Loss) 4,253       4,253
Reclass Upon Adoption of ASU 2018-02 0     469 (469)
Cash Dividends ($.60, $.52 and $.48 in 2018, 2017 and 2016, respectively) (11,842)     (11,842)  
Issuance of Common Stock for:          
3-for-2 Stock Split (in shares)   7,642,726      
3-for-2 Stock Split (29) $ 7,643 (7,672)    
Restricted Share Grants (in shares)   30,246      
Restricted Share Grants 1,246 $ 30 1,216    
Income Tax Benefit From Restricted Share Vesting 0   0    
Ending Balances (in shares) at Dec. 31, 2017   22,934,403      
Ending Balance at Dec. 31, 2017 364,571 $ 22,934 165,288 178,969 (2,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 46,529     46,529  
Other Comprehensive Income (Loss) (4,478)       (4,478)
Cash Dividends ($.60, $.52 and $.48 in 2018, 2017 and 2016, respectively) (14,074)     (14,074)  
Issuance of Common Stock for:          
Acquisitions (in shares)   1,987,698      
Acquisitions 64,737 $ 1,988 62,749    
Restricted Share Grants (in shares)   45,357      
Restricted Share Grants 1,355 $ 45 1,310    
Income Tax Benefit From Restricted Share Vesting 0   0    
Ending Balances (in shares) at Dec. 31, 2018   24,967,458      
Ending Balance at Dec. 31, 2018 $ 458,640 $ 24,967 $ 229,347 $ 211,424 $ (7,098)